Exai Bio

Exai is a precision oncology company. The Company is a spin-out of UCSF, where leading scientists discovered a biomarker called orphan noncoding RNA, or oncRNA, that is exclusively found in cancer cells and not in healthy cells. Exai’s platform has multiple use cases in oncology, including early detection, triage, and evaluating for the presence of residual cancer after treatment.

MILESTONES

Founded in 2021
Partnered in 2022

BASED IN

Palo Alto, CA

CEO

Patrick Arensdorf